(Q71121527)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8648542%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

title

Hydroxyurea therapy in children severely affected with sickle cell disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8648542%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

1 reference

J P Scott

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8648542%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

C A Hillery

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8648542%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

E R Brown

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8648542%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

V Misiewicz

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8648542%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

R J Labotka

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8648542%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

language of work or name

English

0 references

publication date

1 June 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8648542%20AND%20SRC:MED&resulttype=core&format=json

The Journal of Pediatrics

16 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8648542%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

volume

128

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8648542%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8648542%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

page(s)

820-828

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8648542%20AND%20SRC:MED&resulttype=core&format=json

The clinical pathophysiology of sickle cell disease

16 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970335-9

Sickle Cell Vaso-Occlusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970335-9

Sickle cell anemia: Pathophysiology, management, and prospects for the future

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970335-9

The painful crisis of homozygous sickle cell disease: clinical features

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970335-9

Polysaccharide encapsulated bacterial infection in sickle cell anemia: a thirty year epidemiologic experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970335-9

Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970335-9

Increased blood requirements during long-term transfusion therapy for sickle cell disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970335-9

The risk of transfusion-transmitted infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970335-9

Clinical, hematologic and biosynthetic studies in sickle cell-β°-thalassemia: A comparison with sickle cell anemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970335-9

The Ggamma deltabeta-thalassemia and Ggamma-betaO-hpfh conditions in combination with beta-thalassemia and Hb S

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970335-9

Levels of fetal hemoglobin necessary for treatment of sickle cell disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970335-9

Therapeutic approaches to hemoglobin switching in treatment of hemoglobinopathies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970335-9

Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970335-9

Treating sickle cell pain like cancer pain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970335-9

Hematologic Responses of Patients with Sickle Cell Disease to Treatment with Hydroxyurea

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970335-9

Pain in sickle cell disease. Rates and risk factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970335-9

Effect of Chemotherapeutic Agents on Chromosomes of Patients with Lung Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970335-9

A teratogenicity study on hydroxyurea and diphenylhydantoin in cats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970335-9

10.1016/S0022-3476(96)70335-9

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8648542%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

1 reference